Neurocrine Biosciences, Inc. (FRA:NB3)
Germany · Delayed Price · Currency is EUR 115.20
-3.50 (-2.95%)
At close: Jan 9, 2026
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €11.64 billion as of January 9, 2026. Its market cap has decreased by -12.75% in one year.
Market Cap
11.64B
Enterprise Value
11.09B
Revenue
2.29B
Ranking
n/a
PE Ratio
31.91
Stock Price
€115.20
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 11.64B, an increase of 6,855.90%. That is a compound annual growth rate of 15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 11.64B | -3.36% |
| Dec 31, 2025 | 12.04B | -9.77% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |